Metabolomic interplay between gut microbiome and plasma metabolome in cardiac surgery-associated acute kidney injury.

Patients with CSA-AKI may have dysbiosis of their intestinal microbiota and metabolic abnormalities in their gut system before cardiac surgery. Thus, some metabolites and related metabolic pathways may be potential biomarkers and new therapeutic targets for the disease.